| Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248) |
|---|
| 01/12/1993 | CA1312546C Preparation of retrovirus-free immunoglobulins |
| 01/11/1993 | WO1993000881A1 Treatment of hair loss and dermatological problems |
| 01/07/1993 | WO1993000448A1 Methods and compositions for diagnosing lyme disease |
| 01/07/1993 | WO1993000436A1 Papillomavirus l2 protein |
| 01/07/1993 | WO1993000434A1 Capsid forming and cystein modified chimaeric ms2-coat protein |
| 01/07/1993 | WO1993000431A1 Ctl4a receptor, fusion proteins containing it and uses thereof |
| 01/07/1993 | WO1993000365A2 Hepatitis c virus (hcv) polypeptides |
| 01/07/1993 | WO1993000358A1 Pseudomonas exoenzyme s peptide composition and method |
| 01/07/1993 | WO1993000160A1 Multiple emulsions and methods of preparation |
| 01/07/1993 | WO1993000112A1 Attenuated revertant serotype 1 marek's disease vaccine |
| 01/07/1993 | WO1993000111A1 Monoclonal antibody to lymphocyte-associated cell surface protein |
| 01/07/1993 | WO1993000110A1 Method of stimulating immune response |
| 01/07/1993 | WO1993000109A1 Method of stimulating immune response using growth hormone |
| 01/07/1993 | WO1993000077A1 Orally administrable therapeutic proteins and method of making |
| 01/07/1993 | WO1993000051A1 Treatment of diseases by site-specific instillation of cells or site-specific transformation of cells and kits therefor |
| 01/07/1993 | EP0521842A2 Tumor antigen specific antibody |
| 01/07/1993 | EP0521692A2 Inhibition of tumor cell metastasis potential and invasiveness by chemically-defined oligosaccharides, their derivatives, mimetics and antibodies directed to them |
| 01/07/1993 | EP0521318A2 Hepatitis C diagnostics and vaccines |
| 01/07/1993 | EP0521220A1 Recombinant immunogenic actinomycetale |
| 01/07/1993 | DE4209215A1 Hcv peptidantigene und verfahren zur bestimmung von hcv HCV peptide antigens, and methods for the determination of HCV |
| 01/07/1993 | DE4121431A1 Peptide(s) for hepatitis-C virus detection |
| 01/07/1993 | CA2580812A1 Ctla4 receptor, fusion proteins containing it and uses thereof |
| 01/07/1993 | CA2112466A1 Methods and compositions for diagnosing lyme disease |
| 01/07/1993 | CA2112376A1 Treatment of diseases by site-specific instillation of cells or site-specific transformation of cells and kits therefor |
| 01/07/1993 | CA2112356A1 Multiple emulsions and methods of preparation |
| 01/07/1993 | CA2111683A1 Capsid forming and cystein modified chimaeric ms2-coat protein |
| 01/07/1993 | CA2109705A1 Method of stimulating immune response |
| 01/06/1993 | CN1067680A Hepatitis b virus surface proteins with reduced host carbohydrate content |
| 01/06/1993 | CN1067679A Recombinant dha-derived cholera toxin subunit analogs |
| 01/05/1993 | WO1993001210A2 Hcv peptide-antigens and a method of testing for the hepatitis c virus (hcv) |
| 01/05/1993 | US5177194 Process for purifying immune serum globulins |
| 01/05/1993 | US5177022 Immune reactive porous carrier material |
| 01/05/1993 | US5176994 Immunoassay |
| 01/05/1993 | US5176910 Treponema hyodysenteriae hemolysin and uses therefor |
| 01/05/1993 | US5176909 Stable immunogen composition for oral administration |
| 01/05/1993 | US5176908 Method for the treatment of endotoxic shock in mammal |
| 01/05/1993 | CA2089576A1 Hcv peptide antigens and methods for the determination of hcv |
| 01/02/1993 | WO1993000925A1 Isolation and characterization of a novel protease from streptomyces lividans |
| 01/02/1993 | CA2090463A1 Isolation and characterization of a novel protease from streptomyces lividans |
| 01/02/1993 | CA2072824A1 Cluster conjugates of drugs with antibodies |
| 12/30/1992 | EP0520834A2 Pharmaceutical composition for treating an immune system disorder comprising PP14 or antibodies against PP14 |
| 12/30/1992 | EP0520753A1 Recombinant fowlpox vaccine for protection against Marek's disease |
| 12/30/1992 | EP0519986A1 Synthetic polypeptides |
| 12/30/1992 | CN1067382A Human papilloma viral peptide expression and use in immunogenic compositions |
| 12/29/1992 | US5175192 Inhibitors of the advanced glycosylation of proteins and methods of use therefor |
| 12/29/1992 | US5175148 Synthetic peptide; immunocontraceptive agent, diagnosis of autoimmune infertility |
| 12/29/1992 | US5175098 Expression and diagnostic use of gag encoded peptides which are immunologically reactive with antibodies to HIV |
| 12/29/1992 | US5175097 Genetic engineering |
| 12/29/1992 | US5175096 Dna encoding a fibronectin binding protein as well as its preparation |
| 12/29/1992 | US5174993 Immunology |
| 12/29/1992 | CA2064544A1 Immune cell proliferation inhibitors |
| 12/29/1992 | CA1312025C Monoclonal antibodies and antigen for human non-small cell lung carcinomaand certain other human carcinomas |
| 12/29/1992 | CA1312024C Process for preparing hybridoma cells which produce tumour-specific monoclonal antibodies |
| 12/28/1992 | CA2072246A1 Ccv vaccine |
| 12/24/1992 | DE4120281A1 Peptide(s) for hepatitis-C virus detection |
| 12/24/1992 | DE4120213A1 Monoclonal antibodies against TNF-BP I - used for immunoassays to detect TNF-BP I in diagnosis of bacterial infection septic shock, graft versus host disease and cerebral malaria |
| 12/23/1992 | WO1992022666A1 Monoclonal antibodies against human tnf-binding protein i (tnf-bp i) |
| 12/23/1992 | WO1992022662A1 Methods for the synthesis of monofucosylated oligosaccharides terminating in di-n-acetyllactosaminyl structures |
| 12/23/1992 | WO1992022661A1 Methods for the enzymatic synthesis of alpha-sialylated oligosaccharide glycosides |
| 12/23/1992 | WO1992022658A1 Recombinant immunogenic actinomycetale |
| 12/23/1992 | WO1992022656A1 Human p450 iid6 cytochrome-derived peptide fragments, anti peptide fragment antibodies, and applications thereof in the diagnosis of autoimmune hepatitis |
| 12/23/1992 | WO1992022655A1 Hepatitis c diagnostics and vaccines |
| 12/23/1992 | WO1992022653A1 Method for making humanized antibodies |
| 12/23/1992 | WO1992022641A1 Immunodeficiency virus recombinant poxvirus vaccine |
| 12/23/1992 | WO1992022584A1 Monoclonal antibodies specific for marrow-derived mesenchymal cells |
| 12/23/1992 | WO1992022583A2 Tri- and tetra-valent monospecific antigen-binding proteins |
| 12/23/1992 | WO1992022579A1 MIMIC PEPTIDES OF gp120 |
| 12/23/1992 | WO1992022577A1 Immunogen compounds having specifically an anti-cytokine effect, method of preparation, pharmaceutical compositions and kits containing them |
| 12/23/1992 | WO1992022573A1 Detection of mammalian immunodeficiency viruses |
| 12/23/1992 | WO1992022572A1 New hiv-1 gag and env peptides, diagnostic |
| 12/23/1992 | WO1992022565A1 Modified sialyl lewisx compounds |
| 12/23/1992 | WO1992022564A1 Immunosuppressive and tolerogenic modified lewisx and lewisa compounds |
| 12/23/1992 | WO1992022563A1 Modified sialyl lewisa compounds |
| 12/23/1992 | WO1992022329A1 USE OF β-CELL TROPIN (ACTH 22-39) ANTAGONISTS IN THE TREATMENT OF HYPERINSULINAEMIA AND ASSOCIATED DISEASES |
| 12/23/1992 | WO1992022328A1 USE OF β-CELL-TROPIN (ACTH 22-39) ANTAGONISTS IN THE TREATMENT OF TYPE II DIABETES AND ASSOCIATED DISEASES |
| 12/23/1992 | WO1992022327A1 Double recombinant vaccinia virus vaccines |
| 12/23/1992 | WO1992022326A1 Insertional mutations in mycobacteria |
| 12/23/1992 | WO1992022325A1 Vaccine for and method of treating parasitic hemoflagellate protozoa |
| 12/23/1992 | WO1992022324A1 Microbially-produced antibody fragments and their conjugates |
| 12/23/1992 | WO1992022323A1 Intercellular adhesion molecule-3 and its binding ligands |
| 12/23/1992 | WO1992022319A1 SUBSTANTIALLY PURE RECEPTOR LIKE TGF-β1 BINDING MOLECULES AND USES THEREOF |
| 12/23/1992 | WO1992022301A1 Immunosuppressive and tolerogenic oligosaccharide derivatives |
| 12/23/1992 | EP0519903A1 Drug containing activated protein C |
| 12/23/1992 | EP0519866A1 Novel anti-HIV antibodies |
| 12/23/1992 | EP0519596A1 A method for reducing the immunogenicity of antibody variable domains |
| 12/23/1992 | EP0519576A1 Use of a poliovaccine in the treatment of sclerosis multiple |
| 12/23/1992 | EP0519554A1 Conjugates of the class II protein of the outer membrane of neisseria meningitidis and of HIV-1 related peptides |
| 12/23/1992 | EP0519547A2 Coccidiosis poultry vaccine |
| 12/23/1992 | EP0519469A1 Cloned glutamic acid decarboxylase |
| 12/23/1992 | EP0519354A1 A prophylactic/therapeutic composition containing WS7622A for preventing or treating disseminated intravascular coagulation, chronic respiratory tract infectious disease or chronic bronchitis |
| 12/23/1992 | EP0519218A2 Hybrid-plasmid for the 38 kDa antigen from M. tuberculosis, E. coli as host, the 38 kDa antigen and a 33 kDa protein |
| 12/23/1992 | EP0519013A1 Peptides stimulating cytotoxic t cells immune to hiv rt |
| 12/23/1992 | EP0519001A1 PURIFIED gp120 COMPOSITION RETAINING NATURAL CONFORMATION |
| 12/23/1992 | EP0518982A1 Method for enhancing antibody transport through capillary barriers |
| 12/23/1992 | EP0518933A1 Leukaemia inhibitory factor |
| 12/23/1992 | CA2481259A1 Method for making humanized antibodies |
| 12/23/1992 | CA2111681A1 Mimic peptides of gp120 |
| 12/23/1992 | CA2111672A1 Human p450 iid6 cytochrome-derived peptide fragments, anti peptide fragment antibodies, and applications thereof in the diagnosis of autoimmune hepatitis |
| 12/23/1992 | CA2111584A1 Use of b-cell tropin (acth 22-39) antagonists in the treatment of hyperinsulinaemia and associated diseases |
| 12/23/1992 | CA2111583A1 Use of b-cell-tropin (acth 22-39) antagonists in the treatment of type ii diabetes and associated diseases |